A detailed history of Grey Street Capital, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Grey Street Capital, LLC holds 36,403 shares of NVO stock, worth $3.74 Million. This represents 0.64% of its overall portfolio holdings.

Number of Shares
36,403
Previous 17,762 104.95%
Holding current value
$3.74 Million
Previous $1.84 Billion 156.22%
% of portfolio
0.64%
Previous 0.87%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Aug 09, 2024

BUY
$102.11 - $135.92 $1.9 Million - $2.53 Million
18,641 Added 104.95%
36,403 $4.71 Billion
Q4 2023

Jan 11, 2024

BUY
$87.78 - $105.45 $1.56 Million - $1.87 Million
17,762 New
17,762 $1.84 Billion

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $232B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Grey Street Capital, LLC Portfolio

Follow Grey Street Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Grey Street Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Grey Street Capital, LLC with notifications on news.